Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 10-K, Date: 2013-09-26, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: TPI/20130926/10-K/1/000.htm SEC Original: f10k2013_tianyinpharma.htm
FORM 10-K x FOR THE FISCAL YEAR ENDED JUNE 30, 2013 o FOR THE TRANSITION PERIOD FROM TO TIANYIN PHARMACEUTICAL CO., INC. Delaware (State or other jurisdiction of incorporation) (I.R.S. Employer Identification or Organization No.) 23rd Floor, UnionsunYangkuo Plaza No.2, Block 3, Renmin Road South Chengdu, Sichuan, 610041 P. R. China 0086-028-86154737 and principal place of business) Securities registered under

---

---

Webplus: TPI/20130926/10-K/2_EX-31.1/000.htm SEC Original: f10k2013ex31i_tianyinpharma.htm
CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this annual report on Form 10-K of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the

---

---

Webplus: TPI/20130926/10-K/3_EX-31.2/000.htm SEC Original: f10k2013ex31ii_tianyinpharma.htm
CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James J. Tong, certify that: 1. I have reviewed this annual report on Form 10-K of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

---

---

Webplus: TPI/20130926/10-K/4_EX-32.1/000.htm SEC Original: f10k2013ex32i_tianyinpharma.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer

---

---

Webplus: TPI/20130926/10-K/5_EX-32.2/000.htm SEC Original: f10k2013ex32ii_tianyinpharma.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James J. Tong Chief Financial Officer

---

Company Information:

Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 10-K, Date: 2013-09-26, XBRL Interactive FinancialsCIK: 0001362718, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
23RD FLOOR, UNIONSUN YANGKUO PLAZA
CHENGDU, P.R. 610041